ABSTRACT Introduction Cognitive impairment is a common non‐motor symptom of Parkinson's disease (PD) that markedly reduces patients’ quality of life. Given the clinical heterogeneity of PD‐related cognitive impairment (PDCI), further clarification of clinical and circulating biological factors associated with cognitive...
Mei-Lin Gui, Li-Xia Qin, L. Lv et al.· Brain and Behavior· 0 citations
This study defined the serum metabolomic signature of MSA and highlighted novel biomarkers, pathological mechanisms, and therapeutic targets deserving further validation.
Lin-Lin Wan, Zhao Chen, Na Wan et al.· Movement Disorders· 0 citations
This study suggests that polyG protein aggregates in NIID may shift the global RNA splicing profile toward an immature state, potentially through the sequestration of key splicing factors, such as SF3B4, thereby identifying new avenues for understanding the pathogenic mechanisms underlying NIID.
Jia-Xin Yang, You-Qi Zheng, Jian-Yi Hu et al.· Neuroscience Bulletin· 0 citations
This study conducted the first comprehensive Mendelian randomization (MR) analysis of AAO causal determinants in HD, highlighting modifiable biological and lifestyle factors that may underpin future preventive or therapeutic interventions.
Lin-Liu Peng, Zhao Chen, Lin-Lin Wan et al.· Current Neuropharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.